2014
DOI: 10.5858/arpa.2013-0119-oa
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in the Expression of p53, KLF4, and p21 in Neuroendocrine Lung Tumors

Abstract: Context.-Neuroendocrine lung neoplasms are a heterogeneous group of tumors with different clinical behavior and prognosis.Objectives.-To evaluate the expression of p53, KLF4, and p21 in neuroendocrine lung neoplasms and to analyze the influence that expression has on the prognosis of those tumors.Design.-All neuroendocrine lung neoplasms (N ¼ 109) resected in our institution were reviewed, with the collection of histologic slides and paraffin blocks of 47 typical carcinoids (43%), 9 atypical carcinoids (8%), 3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 35 publications
2
12
0
Order By: Relevance
“…Furthermore, we found KLF4 upregulated CRYAB expression and bound the promoter of CRYAB. CRYAB, a human small heat-shock protein, has been found involved in a variety of processes including cytoskeletal assembly, remodeling and apoptosis inhibition [ 14 ]. CRYAB has been reported as a prognostic marker in several cancers, such as breast, renal, thyroid, nasopharyngeal, hepatocellular and lung cancers [ 7 , 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, we found KLF4 upregulated CRYAB expression and bound the promoter of CRYAB. CRYAB, a human small heat-shock protein, has been found involved in a variety of processes including cytoskeletal assembly, remodeling and apoptosis inhibition [ 14 ]. CRYAB has been reported as a prognostic marker in several cancers, such as breast, renal, thyroid, nasopharyngeal, hepatocellular and lung cancers [ 7 , 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Finally, KLF4 plays a key role in cancer progression and development. Mounting evidence shows that KLF4 expression and activity is altered in a large number of human cancers, including gastric [ 10 ], colorectal [ 11 ], esophageal [ 12 ], prostate [ 13 ], lung [ 14 ], bladder [ 15 ], and B-lymphocyte cancers [ 16 ]. KLF4 expression is significantly reduced in all of these tumors, consistent with its roles in cell cycle checkpoints and growth arrest.…”
Section: Introductionmentioning
confidence: 99%
“…It is involved in epidermal barrier function (68), cell proliferation, differentiation and apoptosis (69) and stem cell renewal (70). The activity and expression of KLF4 are often associated with mutation in various cancers (71)(72)(73)(74). Li et al (75), identified that KLF4 was downregulated in OSCC, and its downregulation correlated with cancer differentiation i.e., the poorer the cancer differentiation, the lower the expression of KLF.…”
Section: Saliva-detectable Hypermethylationmentioning
confidence: 99%